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AssessmentThere is evidence from randomized control trials that internet-based cognitive behavioral therapy (iCBT) is efﬁ-
cacious in the treatment of anxiety and depression, and recent research demonstrates the effectiveness of iCBT in
routine clinical care. The aims of this study were to implement and evaluate a new pathway by which patients
could access online treatment by completing an automated assessment, rather than seeing a specialist health
professional. We compared iCBT treatment outcomes in patients who received an automated pre-treatment
questionnaire assessment with patients whowere assessed by a specialist psychiatrist prior to treatment. Partic-
ipants were treated as part of routine clinical care and were therefore not randomized. The results showed that
symptoms of anxiety and depression decreased signiﬁcantly with iCBT, and that themode of assessment did not
affect outcome. That is, a pre-treatment assessment by a psychiatrist conferred no additional treatment beneﬁts
over an automated assessment. These ﬁndings suggest that iCBT is effective in routine care and may be imple-
mentedwith an automated assessment. By providingwider access to evidence-based interventions and reducing
waiting times, the use of iCBTwithin a stepped-caremodel is a cost-effectiveway to reduce the burden of disease
caused by these common mental disorders.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Anxiety and depressive disorders are the most common mental
health disorders (Kessler et al., 2005; Andrews et al., 2001). They can
be treated effectively using cognitive behavioral therapy (CBT;
Roy-Byrne and Cowley, 2007; Barlow, 2008) as well as medication
(e.g., selective serotonin reuptake inhibitors; Montgomery, 2006; Van
Der Linden et al., 2000; Gorman and Kent, 1999). Despite the success
of these interventions, there are signiﬁcant barriers to treatment access
and long-term treatment outcomes. Speciﬁcally, many patients are
reluctant to take medication and relapse rates are elevated once medi-
cation is terminated (e.g., Gould et al., 1995, 1997). Although the effects
of CBT outlast the treatment itself, it is widely recognized that there are
simply not enough trained clinicians to cater for the number of patients
who could beneﬁt from it (Lovell and Richards, 2000; Williams and
Martinez, 2008). This discrepancy between supply and demand has
led to lengthy waiting lists; indeed, waiting times from between 6 and
12 months are not unusual (Lovell and Richards, 2000; Shapiro et al.,
2003). Internet-based treatments, which greatly facilitate the dissemi-
nation of evidence-based interventions, provide a valuable tool for61 2 8382 1402.
. This is an open access article underovercoming this difﬁculty and it is clear that the use of internet-based
treatments has increased dramatically over recent years.
Internet-based cognitive behavioral therapy (iCBT) has been shown
to be efﬁcacious in the treatment of anxiety and depression. Speciﬁcally,
the efﬁcacy of iCBT has been demonstrated in the treatment of General-
ized Anxiety Disorder (Robinson et al., 2010*, Cuijpers et al., 2009),1Social
Anxiety Disorder (Titov et al., 2008b*, Titov et al., 2009a*, Titov et al.,
2009b*, Carlbring et al., 2009), Panic Disorder with and without Agora-
phobia (Wims et al., 2010*, Carlbring et al., 2006), Depression
(Andersson and Cuijpers, 2009; Perini et al., 2009*), and mixed anxiety
and depression (Titov et al., 2011*, Newby et al., 2013*). A recentmeta-
analysis of 22 studies demonstrated that iCBT had a mean effect size of
0.88 (Number needed to treat= 2.13; Andrews et al., 2010). Moreover,
internet treatment has been shown to be as effective as face-to-face
treatment (for review, see Andrews et al., 2010). Further, iCBT is highly
acceptable to patients and adherence rates are high (Andrews et al.,
2010). As one would imagine, iCBT is also more cost-effective than
face-to-face treatment.
There is now also evidence which demonstrates the effectiveness of
iCBT in clinical practice (Williams and Andrews, 2013; Mewton et al.,1 *Referencesmarkedwith an asterisk are published efﬁcacy trials of the courses used in
the current study.
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2013, 2014; Hedman et al., 2013, 2014; Bergstrom et al., 2009; Ruwaard
et al., 2012).We currently have two routes bywhich patients can access
iCBT in routine clinical care— (1) Patients can obtain a referral for a spe-
cialist face-to-face assessment at our clinic and then receive supervision
through the course by one of the clinicians working at the clinic; or
(2) Patients can receive a “prescription” for the iCBT course by their gen-
eral practitioner (GP) who is registered with This Way Up Clinic. In that
pathway, the “prescribing”GP also supervises them through the course.
There are barriers to the uptake of treatment in both of these pathways.
In the specialist pathway, patients are required to attend a face-to-face
clinical interview with a specialist psychiatrist, which is both costly to
the health system and time-consuming for patients. In the primary
care pathway, doctors may feel that they lack the time or expertise
to supervise patients through the course and thus be less inclined to
prescribe an iCBT course for a patient presenting with an anxiety or
depression disorder. Both of these factors limit the extent to which
evidence-based iCBT treatments are used.
In this study, we sought to implement and evaluate a new pathway
in order to overcome these potential barriers to the uptake of iCBT. Spe-
ciﬁcally, we designed a pathway by which patients could access online
treatment by completing an automated assessment, rather than seeing
a specialist health professional, and receive supervision from a clinician
at our clinic rather than from their GP. In this “automated” pathway, the
patient's GP in the community referred the patient for an online assess-
ment to determine suitability for iCBT and course recommendation. Pa-
tients in that pathway received supervision through the course by a
clinician at our clinic, rather than their referring GP. In order to evaluate
this newpathway, treatment outcomes from this group of patients,who
completed an automated assessment, were compared to treatment
outcomes for patients who were seen for a face-to-face assessment.
2. Method
2.1. Participants
Participantswere 308patientswhoenrolled in anonline CRUfADclinic
(now known as This Way Up Clinic) iCBT course between October 2010
and September 2011. 135 of these patients came through the specialist
assessment pathway and the remaining 173 patients came through the
automated assessment pathway. Note that participants were not ran-
domized but rather this was a naturalistic study of these two modes
of assessment that already existed in the clinic. Patients with psychosis,
bipolar disorder, or substance abuse/dependence, as well as patients
who were taking benzodiazepines or were actively suicidal were
excluded from treatment. See Fig. 1 for information on patient ﬂow,
including patient inclusion/exclusion and drop-outs, over the course
of the study.
2.2. Measures
2.2.1. Generalized Anxiety Disorder (GAD)
Generalized Anxiety Disorder (GAD) was assessed by the General-
ized Anxiety Disorder Scale-7 (GAD-7; Spitzer et al., 2006). The GAD-7
is a 7-item measure of the symptoms and severity of GAD (Lowe et al.,
2008). Participants rate each item on a 4-point scale, based on their
symptoms over the past two weeks. Scores range from 0 to 21 and a
score of 10 or higher indicates clinical levels of GAD. The scale has
been shown to have good internal consistency (Cronbach's α= 0.92)
and test–retest reliability (0.83), aswell as criterion and construct valid-
ity for the diagnosis of GAD (Kroenke et al., 2007; Spitzer et al., 2006).
2.2.2. Panic Disorder with or without Agoraphobia
Panic Disorder with or without Agoraphobia was assessed by the 7-
item Panic Disorder Symptom Scale, Self Report form (PDSS-SR; Houck
et al., 2002). Items assess the frequency of panic attacks as well asdistress, fear, avoidance, and impairment in functioning. This scale
ranges from 0 to 28, and a score of 9 or higher indicates a score in the
clinical range (Shear et al., 2001). It has very good internal consistency
(Cronbach's α= 0.92) and test–retest reliability (Houck et al., 2002).
2.2.3. Social Anxiety Disorder
Social Anxiety Disorder was assessed by the Mini-Social Phobia In-
ventory (Mini-SPIN; Connor et al., 2001). This is a 3-item questionnaire,
in which items are rated on a 5-point scale. Scores range from 0 to 12
and clinical Social Anxiety is indicated by a score of 6 or above (Weeks
et al., 2007). The scale has been shown to have sound psychometric
properties, with good internal consistency (Cronbach's α= 0.85) and
reasonable convergent and discriminant validity (Weeks et al., 2007).
2.2.4. Depression
Depressionwas assessedby the PatientHealthQuestionnaire (PHQ-9;
Kroenke et al., 2001). This is a 9-item self-report scale in which partici-
pants rate the frequency of symptoms over the past fortnight. Scores
range from 0 to 27, and a score of 10 or higher indicates clinically signif-
icant levels of Depression (Zuithoff et al., 2010). The PHQ-9 has been
shown to have good sensitivity and speciﬁcity (Wittkampf et al.,
2007) and excellent reliability (Cronbach's α= 0.86–0.89; test–retest
reliability = 0.84) and validity (Kroenke et al., 2001).
2.2.5. General levels of psychological distress
General levels of psychological distress were assessed by the Kessler
Psychological Distress Scale (K10; Kessler et al., 2002). This 10-itemques-
tionnaire measures non-speciﬁc psychological distress over the past
two weeks. Scores range from 10 to 50. Individuals who score less
than 20 are likely to be well; scores between 20 and 24 indicate a
mild level of distress; scores between 25 and 29 indicate a moderate
level of distress; and scores above 30 indicate severe levels of distress.
The K10 has excellent psychometric properties, with high internal
consistency (Cronbach's α= 0.93; Kessler et al., 2002).
2.2.6. Disability
Disability was assessed by the World Health Organization Disability
Assessment II (WHODAS-II; Andrews et al., 2009). This is a 12-item
scale which assesses functional impairment or activity limitation that
is associated with physical illness, mental illness or a combination of
both. Scores range from 0 to 48, with higher scores indicating higher
functional impairment/activity limitation. A score of 10 or above is
thought to indicate clinically signiﬁcant disability (Andrews et al.,
2009). TheWHODAS-II has been shown to possess excellent psychomet-
ric properties,with good internal consistency (Cronbach'sα= 0.86) and
test–retest reliability (0.98) as well as good concurrent validity
(Borkovec et al., 2004).
2.2.7. Suicidality
Suicidality was assessed in the specialist assessment pathway by the
intake psychiatrist. Suicidality in the automated assessment pathway
was assessed by the following screening question — In the last month,
have you thought that your life is not worth living? If patients answered
yes to that question, they were asked the following three questions —
(1) In the last month, have you thought about ending your life?; (2) In
the last month, have you made a plan as to how you might do this?;
and (3) Have you ever in your life made a suicide attempt? Patients
who answered yes to any of the latter three questions were excluded
from treatment.
2.3. Procedure
2.3.1. Assessment
2.3.1.1. Automated assessment group. Participants were referred to
CRUfADclinic (www.crufadclinic.org), now known as This Way Up Clinic
Fig. 1. Participant ﬂow.
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chiatrist, or Primary Health Care Physician). These participants were
provided with a “Referral” code to allow them to access the system.
Once participants logged on to CRUfADclinic, they completed a battery
of self-report questionnaires (see Measures). Based on their scores on
the questionnaires, participants were recommended to do one of the
ﬁve iCBT courses (see treatment section below for details). A simple al-
gorithm was used to determine which course would be recommended
to the patient by the online system — If the patient scored above the
clinical threshold on only one of the symptom questionnaires (PHQ-9,
GAD-7, Mini-SPIN, or PDSS-SR), they were recommended the corre-
sponding course. For example, if the patient scored above threshold
on PHQ-9 only, they were recommended the Depression course. If
patients scored above the clinical threshold on more than one measure
or below threshold on all measures, they were recommended the
Transdiagnostic mixed anxiety and Depression course.
2.3.1.2. Specialist assessment group. Participants were referred by their
doctor (General Practitioner, Psychiatrist, or Primary Health Care Physi-
cian) for assessment at CRUfAD at St Vincent's Hospital. Patients arrived
at the clinic and completed the questionnaire battery on a computer.
They were then seen by a psychiatrist for a clinical interview todetermine their diagnosis and treatment options. If iCBT was deemed
to be appropriate for the patient, they were provided with a “Prescrip-
tion” for the online course, which indicated the prescribed course and
a password in order to access the course. Patients were assigned to
one of the following ﬁve courses based on their primary diagnosis.
The K10, WHODAS-II, and course-speciﬁc measures were again
administered immediately post-treatment for patients who did iCBT.
That is, in addition to the K10 and the WHODAS-II, patients who
completed the Social Anxiety course also completed the Mini-SPIN
post-treatment, patients who completed the Panic disorder course
also completed the PDSS-SR, etc., and patients who completed the
Transdiagnostic mixed anxiety and Depression course also completed
the Mini-SPIN, GAD-7, PDSS-SR, and the PHQ-9. Questionnaires were
re-administered online immediately following the completion of the
ﬁnal lesson, but prior to the download of the homework for that lesson,
to ensure that responses to these questionnaires would be obtained.
This study was approved as part of the quality assurance activities
undertaken by the Patient Safety and Quality Unit at St. Vincent's Hospi-
tal, Sydney, withwhom a copy of thismanuscript has been lodged. Prior
to enrolment in any of the treatment programs, all individuals were in-
formed that data will be collected and used as per the following: “By
participating in This Way Up clinic, you acknowledge that your data will
Fig. 3. Percentage of patients in each group allocated to each course.
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hance scientiﬁc knowledge in anxiety and depression. In any publication,
information will be provided in such a way that you cannot be identiﬁed”.
Patients could opt out of the use of their data for these purposes via
email. All patients provided electronic informed consent that their
pooled data could be used for these purposes.
2.3.2. Treatment
Patients who were accepted for iCBT were able to enroll in the
course immediately. Patients in both groups could choose a course
other than the recommended/prescribed one, though this was not en-
couraged. There were ﬁve courses available to patients — Depression;
Panic Disorder; Generalized Anxiety Disorder; Social Anxiety Disorder;
and the Transdiagnostic course for mixed anxiety and depression. The
course cost patients $44AUD for 90 day access. Courses varied in length,
consisting of 5 or 6 lessons. Each lesson consists of a comic involving a
character with the relevant diagnosis who learns about their disorder
and the CBT skills required to manage their symptoms. Patients then
download a homework summary, which consists of psychoeducation
and various exercises such as cognitive restructuring and developing
an exposure hierarchy. Patients were encouraged to spend between 3
and 4 h a week on the course.
Patients logged on to complete each lesson. They were able to com-
plete lessons at their own pace with the limitations that the ﬁrst two les-
sons needed to be completed within 30 days of registering and the entire
course needed to be completedwithin 90 days, although extensionswere
granted in some cases to allow patients who were slow to complete the
lessons to ﬁnish the course (see Results). During the course, all patients
received email contact from their clinician (a clinical psychologist or
psychiatry registrar) working at the Anxiety Disorders Clinic at CRUfAD.
Patients could contact their clinician by email or phone throughout treat-
ment, though email was the most frequently used form of contact. At the
very least, clinicians contacted their patients via email after the ﬁrst,
second, and last lessons. Clinicians also responded to any patient contact
made. Prior to each lesson, patients completed the K10 questionnaire to
assess their level of emotional distress. Clinicians contacted patients
who exhibited an increase of 5 points or an increase to a score of 30 or
above on this measure between lessons. Clinicians primarily contacted
patients to encourage them to complete the lessons and to respond to
questions clarifying the content of the course.
2.4. Data analysis
Cohen's d within-group effect sizes were calculated based on the
pooled standard deviations, and adjusted for the correlation between
the means. When reporting independent t-tests, in cases where the as-
sumption of equal variances between groups was violated (as indicated
by Levine's Test for Equality of Variances), the nominal degrees of free-
domand adjusted p-value are reported. These cases are indicated by the
subscript UV (i.e., Unequal Variances), and appear as pUV.Fig. 2.Mean pre-treatment scores for patients in the specialist assessment and automated asses
represent the standard error of the mean (SEM). * indicates a signiﬁcant difference between g3. Results
3.1. Demographics
51.9% of the specialist assessment group were female (n = 70) and
72.3% of the automated assessment group were female (n = 125).
The mean age of patients in the specialist assessment group was
36 years (SD = 12) and the mean age in the automated assessment
group was 40 years (SD = 14).
3.2. Pre-treatment severity
Mean scores acrossmeasures at baseline are shown in Fig. 2. Patients
in the specialist assessment group reported more distress than patients
in the automated assessment group [t(271) = 2.56, pUV = 0.015].
Patients in the specialist group also reported more severe symptoms
of GAD [t(272) = 2.19, p = 0.03] and Panic Disorder [t(276) = 4.53,
pUV b 0.001] than patients in the automated group. There were no
signiﬁcant differences between groups on measures of Depression
[t(271) = 1.91, pUV = 0.07], Social Anxiety [t(263) = 1.75, pUV =
0.09], or Disability [t(302) = 0.56, p= 0.57].
3.3. Course allocation
The percentage of patients in each course is shown in Fig. 3.
3.4. Adherence and length of course
67.4% of patients in the specialist assessment group completed their
course and 61.3% of patients in the automated assessment pathway
completed their course. This difference between groups was not signif-
icant (χ2 = 1.24, p= 0.27).sment groups: (a) Symptom scores; (b) distress and disability. N.B. Error bars in all graphs
roups.
Fig. 4. Pre- and post-treatment (a) Distress across courses; (b) disability across courses.
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assessment patients were provided with extensions to allow them to
complete the course. This was a signiﬁcant difference between groups
(χ2 = 8.83, p= 0.003).
When the analyses were restricted to patients who were not given
course length extensions, 60.9% of patients in the specialist assessment
group completed their course and59.4%of patients in the automated as-
sessment group completed their course, suggesting that the difference
between groups in the number of extensions given did not have a
meaningful impact on adherence rates.3.5. Post-treatment symptom scores
Mean post-treatment symptom scores for treatment completers are
shown in Figs. 4 and 5. Relative to pre-treatment scores, at post-
treatment, both groups reported signiﬁcant reductions in distress,
[F(1, 173) = 187.24, p b 0.001] and disability [F(1, 195) = 84.69,
p b 0.001]. There was also a time-by-group interaction on the measure
of distress [F(1, 173) = 5.77, p= 0.02], reﬂecting a difference between
groups at baseline [t(173) = 2.24, p= 0.03] but not at post-treatment
[t(195) = 0.16, p= 0.88]. There was no time-by-group interaction on
the measure of disability [F(1, 195) = 1.46, p= 0.23] and no main ef-
fect of group on either of these measures [largest F(1, 173) = 1.71,
p= 0.19]. Collapsing across groups, the within-group effect size for re-
ductions in distress over treatment was 1.05 (95% conﬁdence interval,
CI: 0.83–1.25) and the effect size for reductions in disability was 0.54
(95% CI: 0.34–0.84). At the end of treatment, 66.0% of participants
scored in the “well” range on the K10, 17.3% scored in the mild range,
and the remaining 16.8% scored in the moderate or severe range. At
the end of treatment, 57.9% of participants scored in the range indicat-
ing no clinically signiﬁcant disability on the WHODAS.
Patients in both groups who completed the Depression course
reported signiﬁcant reductions in their Depression severity [F(1, 14) =
21.33, p b 0.001]. There was also a signiﬁcant group-by-time interaction
[F(1, 14) = 5.35, p = 0.04], reﬂecting a difference between groups at
baseline2 [t(14) = 3.01, p = 0.009] but not at post-treatment on this
measure [t(16) = 0.47, p = 0.64]. There was no main effect of group
[F(1, 14) = 1.07, p= 0.32]. Collapsing across groups, the within-group
effect size (Cohen's d) for reductions in Depression over treatment
in patients who completed the Depression course was 1.10 (95% CI:
0.40–1.80). At the end of treatment, 72.2% of participants who completed
the Depression course scored in the non-clinical range on the PHQ-9.
Patients in both groups who completed the GAD course reported
signiﬁcant reductions in their GAD severity [F(1, 45) = 68.09,
p b 0.001]. There was no interaction [F b 1] and no main effect of
group [F(1, 45) = 2.62, p = 0.11]. Collapsing across groups, the
within-group effect size (Cohen's d) for reductions in GAD over treat-
ment in patients who completed the GAD course was 1.14 (95% CI:2 Note that this difference between groups wasn't present in the pre-treatment scores
which included all patients. That is, this difference was only apparent in the subset of pa-
tients who completed the Depression course.0.73–1.55). At the end of treatment, 84.3% of participantswho completed
the GAD course scored in the non-clinical range on the GAD-7.
Patients in both groupswho completed the Panic course reported sig-
niﬁcant reductions in their Panic Disorder severity [F(1, 31) = 51.24,
p b 0.001]. There was no interaction [F(1, 31) = 2.14, p = 0.15]
and no main effect of group [F b 1]. Collapsing across groups, the
within-group effect size (Cohen's d) for reductions in Panic symptoms
over treatment in patients who completed the Panic course was 1.46
(95% CI: 0.97–1.95). At the end of treatment, 69.2% of participants
who completed the Panic course scored in the non-clinical range on
the PDSS-SR.
Patients in both groups who completed the Social Anxiety
course reported signiﬁcant reductions in their Social Anxiety sever-
ity [F(1, 34) = 57.27, p b 0.001]. There was no interaction and nomain
effect of group [both Fs b 1]. Collapsing across groups, the within-group
effect size (Cohen's d) for reductions in Social anxiety over treatment in
patients who completed the Social course was 1.33 (95% CI: 0.87–1.79).
At the end of treatment, 48.8% of participants who completed the Social
Anxiety course scored in the non-clinical range on the Mini-SPIN.
Patients in both groups who completed the Transdiagnostic mixed
anxiety and Depression course reported signiﬁcant reductions in symp-
toms of Depression [F(1, 38) = 20.75, p b 0.001], (d = 0.86; 95% CI:
0.42–1.30), GAD [F(1, 38) = 20.09, p b 0.001], (d = 0.94; 95% CI:
0.50–1.38), Social Anxiety [F(1, 37) = 8.76, p = 0.005], (d = 0.47;
95% CI: 0.03–0.91), and Panic Disorder [F(1, 38) = 6.13, p = 0.018],
(d = 0.55; 95% CI: 0.11–0.99). There were no signiﬁcant time-by-
group interactions [largest F(1, 38) = 1.06, p= 0.31] and no main ef-
fects of group across measures [all Fs b 1]. At the end of treatment,
amongst patients who completed the Transdiagnostic anxiety and
Depression course, 78.3% scored in the non-clinical range on the PHQ-
9, 84.8% scored in the non-clinical range on the GAD-7, 73.9% scored
in the non-clinical range on the PDSS-SR, and 73.9% scored in the non-
clinical range on the Mini-SPIN.
3.6. Completers and non-completers — change in distress across lessons
Lesson-by-lesson K10 scores for course completers and non-
completers can be found in Table 1. Collapsed across specialist and
automated groups, there were no differences between completers'
and non-completers' distress levels at any lesson [largest t(264), lesson
4, = 0.87, p= 0.39].
4. Discussion
This study demonstrated that internet-based cognitive behavioral
therapy is effective in routine clinical care regardless of whether
patients came via a pathway that involved a specialized assessment by
a psychiatrist or via a pathway that involved an automated online as-
sessment. Prior to treatment, there were minor differences between
groups in terms of symptom severity. Speciﬁcally, patients in the
specialist assessment group were more distressed, and also reported
more symptoms of GAD and Panic Disorder than patients in the auto-
mated assessed group. Nevertheless, distress, disability and symptom
Fig. 5. Pre- and post-treatment (a) Depression severity scores for patients who completed the Depression course; (b) GAD severity scores for patients who completed the GAD course;
(c) Panic Disorder severity scores for patients who completed the Panic course; (d) Social Anxiety severity scores for patients who completed the Social Anxiety course; (e) symptom
scores for patients who completed the Transdiagnostic course.
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cantly for both groups over treatment, and there were no differences
between groups at post-treatment.
4.1. Adherence
Adherence rates, deﬁned as the completion of all lessons, for the spe-
cialist assessment groupwere the same as in the automated assessment
group. It is of interest, however, that more extensions were granted to
patients in the specialist assessment group than to patients in the auto-
mated assessment group. This may be due to the fact that at the start of
treatment, the patients in the specialist assessment group were often
met in person by their supervising clinician, whereas patients in the on-
line assessment group were never met in person by their supervising
clinician. This might have led the supervising clinicians to feel more
obliged to give extensions to the patients they had actually met andmay have also resulted in the specialist assessed patients feeling more
comfortable to request extensions than automated assessed patients.
Whatever the reason for the difference between groups in the number
of extensions provided, it is worth noting that the provision of exten-
sions did not have a meaningful impact on course adherence rates.
When the analyses were restricted only to patients who did not receive
an extension, both groups' adherence rates were similar, and very close
to those obtained when patients who were given extensions were
included in the analyses.
The overall adherence rate across groups in this study was 64%.
Across the 22 randomized control trials of iCBT included in Andrews
et al.'s (2010) meta-analysis of iCBT, the median rate of adherence
was 80%. Therefore, the adherence rate in the current study is lower
than those achieved in research iCBT trials, which is to be expected
given that this was conducted in a routine care, where adherence has
been shown to be lower than in formal clinical trials. Indeed, adherence
Table 1
K10 (distress) scores for completers and non-completers across lessons.
Lesson
Mean K10 score
(SEM; n)
1 2 3 4 5 6
Six lesson courses Completers Specialist 25.6
(0.7; 80)
22.9
(0.7; 80)
20.6
(0.7; 80)
19.8
(0.8; 80)
19.5
(0.8; 80)
18.1
(0.7; 80)
Automated 24.1
(0.7; 90)
22.5
(0.7; 90)
20.7
(0.6; 90)
19.5
(0.7; 90)
18.9
(0.6; 90)
17.4
(0.6; 90)
Non-completers Specialist 25.4
(1.3; 36)
23.8
(1.4; 35)
21.1
(1.5; 31)
22.1
(1.8; 28)
21.7
(2.5; 19)
18.0
(1.9; 13)
Automated 25.3
(0.9; 58)
23.2
(1.0; 51)
21.2
(1.0; 42)
19.4
(1.1; 34)
18.0
(1.4; 22)
15.3
(2.3; 3)
Five lesson courses Completers Specialist 22.9
(2.6; 11)
20.5
(2.0; 11)
17.8
(1.7; 11)
16.7
(1.5; 11)
14.4
(1.3; 11)
Automated 24.5
(1.7; 16)
23.1
(2.0; 16)
21.3
(2.0; 16)
20.1
(2.0; 16)
19.6 (1.9)
Non-completers Specialist 26.7
(4.2; 7)
23.3
(4.6; 7)
22.8
(6.7; 5)
18.3
(5.0; 4)
15.3
(4.1; 3)
Automated 23.0
(4.0; 6)
18.8
(1.8; 5)
16.0
(3.0; 4)
17.3
(3.7; 3)
14.0
(–; 1)
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effectiveness trials conducted in routine clinical care (Williams and
Andrews, 2013; ~55% adherence, Newby et al., 2014; ~50% adherence).
Recent work has examined ways in which to improve adherence rates
for iCBT in routine care (Hilvert-Bruce et al., 2012). In particular,
Hilvert-Bruce et al. (2012) found that the inclusionof automated patient
reminders to complete lessons and a course fee, as well as the provision
of course choice and the inclusion of a calendar system inwhichpatients
nominated when they would next complete a lesson, increased adher-
ence rates to some 60%. Those strategies were included in the current
study and therefore, it is clear that there is still room for improvement
in adherence rates for iCBT used in routine clinical care. This ﬁeld
would beneﬁt from further research to identify additional factors to
improve adherence rates.
As can be seen in Table 1,whether courses areﬁve or six lessons does
not appear to affect outcome. Importantly, what is also clear is that both
non-completers and completers reported a reduction in distress across
lessons completed. The ﬁnding that non-completers still derive some
beneﬁt from the online CBT course is consistent with what has been ob-
served previously (Hilvert-Bruce et al., 2012). Although, the reasons for
non-completion are not known, there appears to be subset of patients
who do not complete treatment who have made good progress in re-
ducing their distress and may therefore have a positive reason for con-
cluding early.
4.2. Course allocation
It is worth noting that there were differences between groups in
terms of their course allocation. This might reﬂect a greater number of
patients with Depression coming through the automated assessment
route, as compared to the specialized assessment group. It also likely re-
ﬂects the fact that the automated assessment was biased towards
recommending the Transdiagnostic mixed anxiety and depression
course, given that any comorbity led to the Transdiagnostic course
being recommended. In contrast, patients who came through the
specialist assessment pathway did the course recommended by the
psychiatrist who assessed them, who may have been more likely to
recommend the course that corresponded to the patient's primary
diagnosis, with the assumption that any comorbid condition, that was
perhaps secondary to the primary condition, would remit with effective
treatment of the primary disorder.
4.2.1. Clinical implications
This research has important implications for clinical practice in the
treatment of anxiety and depression. One, it suggests that internet-based CBT courses for anxiety and depressive disorders have utility in
routine care. Two, this research suggests that specialist assessments
and initial face-to-face contact do not inﬂuence treatment outcome,
and that patients do just as well with an automated assessment. The
use of automated assessments has clear beneﬁts related to cost and
waiting times.
When reﬂecting on this ﬁnding, one might be tempted to wonder
whether clinicians are required at all in the treatment of patients
using online CBT. Although this study suggests that having a clinician
at the assessment stage does not inﬂuence treatment outcome, there
is reason to believe that having someone (though not necessarily a
specialized clinician) to support patients through online treatment
does affect the outcome of treatment. That is, guided iCBT has been
shown to lead to better outcomes than non-guided iCBT. For example,
in a trial examining iCBT for Social Anxiety Disorder, Titov and
colleagues found that 77% of patients in the clinician-assisted group
completed all of the lessons and only 33% of patients in the self-
guided condition completed all lessons (Titov et al., 2008a). Despite
the importance of guidance through iCBT, it appears as though the per-
son providing the guidance does not need to be a specialized clinician.
For example, Robinson et al. (2010) and Titov et al. (2010) found that
regardless of whether a clinician or technician supervised patients
through the online course, treatment outcome was the same, and was
comparable to that associated with face-to-face treatment.
Onemight argue that a limitation of using an automated assessment
is that this approach does not afford the opportunity to provide patients
who may not beneﬁt from iCBT for anxiety and/or depression with
alternative treatment recommendations, for example, if they meet
criteria for another disorder or might beneﬁt more from a different
form of therapy. However, if this was a major problem in that automat-
ed assessment led to more inappropriate patients starting an iCBT
course than did specialist assessment, then one would expect to have
observed poorer treatment outcomes in the automated assessment
group in the current study, and/or that adherence rates would have
been lower in the automated group relative to the specialist group.
Clearly, this was not shown to be the case in the present study. Further,
a fairly simplistic automated assessment and algorithm for course rec-
ommendations were used in the current study and there is certainly
scope to develop more sophisticated online assessment algorithms for
treatment recommendations in this area. Indeed, a more sophisticated
algorithmmight better be able to distinguish between primary and sec-
ondary diagnoses and make superior treatment recommendations
based on this. In addition, the use of online structured diagnostic tools
might increase diagnostic reliability. It should also be noted that a stan-
dardized clinical interview such as the SCIDwas not used in the current
223E.C. Mason, G. Andrews / Internet Interventions 1 (2014) 216–224study and therefore it is possible that diagnosis reliability could also
have been enhanced in the specialist group. Finally, it should also be
pointed out that a fairly conservative approach to suicide assessment
was used in the automated group and given that our group have since
shown that suicidal ideation can be reduced with iCBT (Watts et al.,
2012), it is likely these criteria could be less restrictive in the future.
More than half a century ago, Meehl (1954) argued that statistical
prediction consistently outperforms clinical judgment, for example in
relation to diagnosing and planning optimal treatment. In 1965, he
reviewed 51 studies that almost all conﬁrmed this earlier conclusion
(Meehl, 1965). As noted by Dawes et al. (1989), “Optimal planning and
care often hinge on the consultant's judgmental accuracy” (p. 1668).
Nevertheless, it is clear that many professionals, including psychiatrists
and psychologists, tend to rely on their own judgment over indications
provided by actuarial methods. Indeed, we predicted that patients who
were assessed by a specialist would do better in treatment than those
assessed by a computer because we expected that the specialists would
be better at diagnosing and selecting patients who would most beneﬁt
from iCBT, as well as matching patients to the most appropriate iCBT
course. The fact that both groups of patients did as well as each other
in treatment suggests that clinical judgment in these circumstances pro-
vides no additional beneﬁt over the use of an automated assessment.
With the current state of knowledge in the ﬁeld, however, we don't
possess the information to predict accurately who will beneﬁt from
CBT, whether delivered in the traditional face-to-face format or over
the internet. It is likely that once more research is conducted that pro-
vides information on factors that accurately predict who will beneﬁt
from CBT, both modes of assessment (automated/actuarial and special-
ist) will beneﬁt and improve in their predictive ability to select patients
who are most likely to beneﬁt from treatment so that we can truly
optimize treatment for patients with these common mental disorders.
It is important to note that a key limitation of the current study was
that participants were not randomized to the two groups and therefore
it is possible that sample differences may play a role in these ﬁndings.
The current ﬁndings would be strengthened by future research in
which participants were randomized into the two forms of assessment
and compared.
4.3. What about patients who don't beneﬁt from iCBT?
Of course, as with all treatments, a subset of patients drop out of
treatment and even of those who do adhere, a subset will not achieve
signiﬁcant gains. In the clinic in which this study was conducted, iCBT
is used within a stepped-care model, by which patients are ﬁrst treated
with iCBT and then if they require further treatment at the end of iCBT,
they go on to be treated with face-to-face therapy. Although this model
has intuitive practical appeal, it is unclear whether patients who do not
beneﬁt from iCBTwill beneﬁt from face-to-face CBT. This is an empirical
question, which would be an interesting avenue for future research.
4.4. Conclusions
In the treatment of mental disorders, it has long been believed that
seeing people face-to-face is important. However, with the rapidly
emerging ﬁeld of internet-based interventions for mental disorders, it
is now becoming increasingly accepted that therapy over the internet
leads to signiﬁcant therapeutic gains. Nevertheless, a specialized assess-
ment in person or over the phone continues to be the norm in this ﬁeld.
In this study, we showed that not only can patients in real-world set-
tings beneﬁt signiﬁcantly from online cognitive behavioral therapy for
anxiety and depression, but that the pre-treatment assessment can
also be completed online, without any therapist involvement, without
compromising treatment outcome. These ﬁndings have implications
for the treatment of anxiety and depressive disorders in routine clinical
practice. In particular, they suggest that specialized mental health
clinicians may not be essential for the online treatment of anxiety anddepression. Using an automated assessment and online treatment can
greatly lessen the burden of disease related to anxiety and depression
by reducing waiting times and signiﬁcantly increasing access to
evidence-based interventions. Future work should continue to examine
further factors that inﬂuence treatment outcome, and ways in which to
increase adherence rates in real-world settings.References
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